KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Total Current Liabilities (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Total Current Liabilities data on record, last reported at $1.1 billion in Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 7.58% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, up 7.58%, while the annual FY2025 figure was $1.1 billion, 7.58% up from the prior year.
  • Total Current Liabilities reached $1.1 billion in Q4 2025 per IDXX's latest filing, down from $1.3 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $1.3 billion in Q3 2025 and bottomed at $620.7 million in Q1 2021.
  • Average Total Current Liabilities over 5 years is $1.0 billion, with a median of $1.0 billion recorded in 2023.
  • Peak YoY movement for Total Current Liabilities: dropped 26.66% in 2021, then surged 87.73% in 2022.
  • A 5-year view of Total Current Liabilities shows it stood at $763.6 million in 2021, then skyrocketed by 61.84% to $1.2 billion in 2022, then fell by 23.0% to $951.5 million in 2023, then rose by 12.23% to $1.1 billion in 2024, then increased by 7.58% to $1.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $1.1 billion in Q4 2025, $1.3 billion in Q3 2025, and $1.2 billion in Q2 2025.